13 results on '"Motilla de la Cámara, Marta"'
Search Results
2. Protocol for the implementation of a screening tool for the early detection of nutritional risk in a university hospital
- Author
-
García-Peris, Pilar, Velasco Gimeno, Cristina, Frías Soriano, Laura, Higuera Pulgar, Isabel, Bretón Lesmes, Irene, Camblor Álvarez, Miguel, Motilla de la Cámara, Marta, and Cuerda Compés, Cristina
- Published
- 2019
- Full Text
- View/download PDF
3. Protocolo de implantación de un cribado para la detección precoz del riesgo nutricional en un hospital universitario
- Author
-
García-Peris, Pilar, Velasco Gimeno, Cristina, Frías Soriano, Laura, Higuera Pulgar, Isabel, Bretón Lesmes, Irene, Camblor Álvarez, Miguel, Motilla de la Cámara, Marta, and Cuerda Compés, Cristina
- Published
- 2019
- Full Text
- View/download PDF
4. Comparison of differentiated thyroid carcinoma staging systems in a Spanish population
- Author
-
Andía Melero, Víctor Manuel, Martín de Santa-Olalla Llanes, María, Sambo Salas, Marcel, Percovich Hualpa, Juan Carlos, Motilla de la Cámara, Marta, and Collado Yurrita, Luis
- Published
- 2015
- Full Text
- View/download PDF
5. Late-onset methylmalonic acidemia and homocysteinemia
- Author
-
Brox-Torrecilla,Noemi, Arhip,Loredana, Miguélez-González,María, Castellano-Gasch,Sandra, Contreras-Chicote,Ana, Rodríguez-Ferrero,María Luisa, Motilla-de la Cámara,Marta Luisa, Serrano-Moreno,Clara, and Cuerda Compes,Cristina
- Subjects
Methylmalonic acidemia ,Hyperhomocysteinemia ,Cobalamin C - Abstract
Introduction: cobalamin C (Cbl C) deficiency is the most common defect in intracellular cobalamin metabolism, associated with methylmalonic acidemia and homocystinuria. Its late clinical presentation is heterogeneous and may lead to a diagnostic delay. Case report: we report the case of a 45-year-old man with a 20-year history of chronic kidney disease and recently diagnosed spastic paraparesis, both of unknown origin. Metabolic studies revealed elevated levels of homocysteine and methylmalonic acid in the blood and urine. A genetic study confirmed cobalamin C deficiency. Treatment with hydroxocobalamin, betaine, carnitine, and folic acid was started. The patient eventually received a kidney transplant. Discussion: early diagnosis and appropriate treatment improve the clinical evolution of patients with Cbl C deficiency. Determination of homocysteine, organic acids, and other amino acids should be included in the differential diagnosis of patients with nephrological-neurological symptoms without a clear etiology.
- Published
- 2021
6. Clinical and economic impact of the taurolidine lock on home parenteral nutrition
- Author
-
Arnoriaga Rodríguez, María, Pérez de Ciriza Cordeu, Maite, Camblor Álvarez, Miguel, Bretón Lesmes, Irene, Motilla de la Cámara, Marta, Velasco Gimeno, Cristina, Arhip, Loredana, García Peris, Pilar, and Cuerda Compés, Cristina
- Subjects
Taurolidine ,Infecciones asociadas al catéter (IAC) ,Catheter-related bloodstream infection (CRBSI) ,Home parenteral nutrition (HPN) ,Taurolidina ,Nutrición parenteral domiciliaria (NPD) ,Costes ,Catéter venoso central (CVC) ,Central venous catheter (CVC) ,Costs - Abstract
Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI. Resumen Introducción: las infecciones asociadas al catéter (IAC) son una de las complicaciones más serias en pacientes con nutrición parenteral domiciliara (NPD), generando una alta morbilidad y costes sanitarios. En los últimos años, el sellado con taurolidina ha demostrado ser eficaz en su prevención, si bien la evidencia en cuanto a su eficiencia es escasa. Objetivo: determinar si el sellado del catéter con taurolidina es una intervención coste-efectiva en pacientes con NPD. Materiales y métodos: estudio retrospectivo de pacientes con NPD que recibieron sellados con taurolidina. Comparamos la incidencia de IAC antes y durante el tratamiento y los costes asociados. Resultados: el estudio incluyó trece pacientes, seis (46%) varones y siete (54%) mujeres, con edad media de 61,08 (± 14,18) años y un seguimiento de 12.186 y 5.293 días antes y durante el uso de taurolidina. La enfermedad de base era benigna en cinco pacientes (38,5%) y maligna en ocho (61,5%). La tasa de IAC antes y durante el sellado con taurolidina fue de 3,12 vs. 0,76 episodios por 1.000/días de catéter (p = 0,0058). Cuando la indicación fue por alta tasa de IAC, esta fue de 9,72 vs. 0,39 (p < 0,001) episodios por 1.000/días de catéter antes y durante el tratamiento. No hubo diferencias en la tasa de oclusión del catéter en ambos periodos. No se reportaron efectos adversos. El coste total de las IAC antes y durante el uso de taurolidina fue de 151.264,14 euros vs. 24.331,19 euros. Conclusiones: nuestro estudio muestra que los sellados con taurolidina son coste-efectivos en pacientes con NPD con alta tasa de infección.
- Published
- 2019
7. Late-onset methylmalonic acidemia and homocysteinemia: a case report
- Author
-
Brox-Torrecilla, Noemí, primary, Arhip, Loredana, additional, Miguélez-González, María, additional, Castellano-Gasch, Sandra, additional, Contreras-Chicote, Ana, additional, Rodríguez-Ferrero, María Luisa, additional, Motilla de la Cámara, Marta Luisa, additional, Serrano-Moreno, Clara, additional, and Cuerda Compes, Cristina, additional
- Published
- 2021
- Full Text
- View/download PDF
8. Clinical and economic impact of the taurolidine lock on home parenteral nutrition
- Author
-
Arnoriaga Rodríguez, María, primary, Pérez de Ciriza Cordeu, Maite, additional, Camblor Álvarez, Miguel, additional, Bretón Lesmes, Irene, additional, Motilla de la Cámara, Marta, additional, Velasco Gimeno, Cristina, additional, Arhip, Loredana, additional, García-Peris, Pilar, additional, and Cuerda Compés, Cristina, additional
- Published
- 2018
- Full Text
- View/download PDF
9. Comparación de sistemas de estadificación del carcinoma diferenciado de tiroides en una población española
- Author
-
Andía Melero, Víctor Manuel, primary, Martín de Santa-Olalla Llanes, María, additional, Sambo Salas, Marcel, additional, Percovich Hualpa, Juan Carlos, additional, Motilla de la Cámara, Marta, additional, and Collado Yurrita, Luis, additional
- Published
- 2015
- Full Text
- View/download PDF
10. Acidemia metilmalónica y homocisteinemia de inicio tardío.
- Author
-
Brox-Torrecilla, Noemi, Arhip, Loredana, Miguélez-González, María, Castellano-Gasch, Sandra, Contreras-Chicote, Ana, Luisa Rodríguez-Ferrero, María, Motilla-de la Cámara, Marta Luisa, Serrano-Moreno, Clara, Cuerda Compes, Cristina, Brox-Torrecilla, Noemí, and Rodríguez-Ferrero, María Luisa
- Subjects
- *
VITAMIN B12 , *METHYLMALONIC acid , *HOMOCYSTINURIA , *AMINO acid metabolism disorders , *CARNITINE , *CHRONIC kidney failure , *DELAYED diagnosis , *VITAMIN deficiency , *HYPERHOMOCYSTEINEMIA , *DISEASE complications ,CHRONIC kidney failure complications - Abstract
Introduction: Introduction: cobalamin C (Cbl C) deficiency is the most common defect in intracellular cobalamin metabolism, associated with methylmalonic acidemia and homocystinuria. Its late clinical presentation is heterogeneous and may lead to a diagnostic delay. Case report: we report the case of a 45-year-old man with a 20-year history of chronic kidney disease and recently diagnosed spastic paraparesis, both of unknown origin. Metabolic studies revealed elevated levels of homocysteine and methylmalonic acid in the blood and urine. A genetic study confirmed cobalamin C deficiency. Treatment with hydroxocobalamin, betaine, carnitine, and folic acid was started. The patient eventually received a kidney transplant. Discussion: early diagnosis and appropriate treatment improve the clinical evolution of patients with Cbl C deficiency. Determination of homocysteine, organic acids, and other amino acids should be included in the differential diagnosis of patients with nephrological-neurological symptoms without a clear etiology. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. Two pregnancies of an ornithine carbamoyltransferase deficiency disease carrier and review of the literature.
- Author
-
Arhip L, Agreda J, Serrano-Moreno C, Motilla de la Cámara M, Carrascal Fabián ML, Bielza A, Velasco Gimeno C, Camblor M, Bretón Lesmes I, and Cuerda C
- Subjects
- Humans, Female, Pregnancy, Adult, Pregnancy Complications genetics, Postpartum Period, Heterozygote, Ornithine Carbamoyltransferase Deficiency Disease genetics, Ornithine Carbamoyltransferase Deficiency Disease diagnosis, Ornithine Carbamoyltransferase Deficiency Disease therapy
- Abstract
Introduction: Background: the underlying cause of the deficiency of ornithine carbamoyltransferase (OTCD) is a gene mutation on the X chromosome. In females, the phenotype is highly variable, ranging from asymptomatic to neurologic compromise secondary to hyperammonemia and it can be prompted by numerous triggers, including pregnancy. Objective: the objective of this article is to report a case of two pregnancies of an OTCD-carrier, and to review the literature describing OTCD and pregnancy, parturition and postpartum. Methods: an extensive search in PubMed in December 2021 was conducted using different search terms. After screening all abstracts, 23 papers that corresponded to our inclusion criteria were identified. Results: the article focuses on the management of OTCD during pregnancy, parturition, and the postpartum period in terms of clinical presentation, ammonia levels and treatment. Conclusions: females with OTCD can certainly plan a pregnancy, but they need a careful management during delivery and particularly during the immediate postpartum period. If possible, a multidisciplinary team of physicians, dietitians, obstetrician-gynecologist, neonatologists, pharmacists, etc. with expertise in this field should participate in the care of women with OTCD and their children during this period and in their adult life.
- Published
- 2024
- Full Text
- View/download PDF
12. Implementation of a parenteral nutrition home care programme in a tertiary hospital.
- Author
-
Arhip L, Camblor M, Bretón I, Motilla de la Cámara M, Serrano-Moreno C, Romero Jiménez RM, Lobato Matilla E, Frías Soriano L, Velasco Gimeno C, Carrascal Fabián ML, and Cuerda C
- Subjects
- Humans, Female, Male, Retrospective Studies, Tertiary Care Centers, Catheters, Home Care Services, Parenteral Nutrition, Home methods
- Abstract
Introduction: Aim: the objective of this study was to describe the results of the implementation of a home parenteral nutrition (HPN) care programme (Nutrihome©) in a cohort of patients treated at a tertiary hospital. Methods: retrospective study of the patients included in Nutrihome© at Hospital General Universitario Gregorio Marañón, Madrid, Spain. Nutrihome consists of different modules including pre-discharge nursing hospital visits and nursing home visits, deliveries of the infusion pump, consumables and parenteral nutrition bags, patient training, weekly scheduled nursing home visits, scheduled nursing phone calls, stock control phone calls and 24-hour on-call line manned by the nurses. Results: the study included 8 (75 % women) and 10 (70 % women) patients in the Nutrihome© pilot and Nutrihome© programme, respectively. A total 37 adverse events were reported during Nutrihome© pilot, 26 of which were technical, 9 clinical, 1 was catheter-related and 1 other event. Nutrihome© programme registered a total of 107 adverse events reported, 57 of which were technical, 21 clinical, 16 were catheter-related and 13 were other events. A total of 99 % of these events were solved by Nutrihome© via phone calls or home visits. Conclusions: Nutrihome© programme has been extremely useful during this pandemic, facilitaing both the start of HPN and training at the patient home without the need for hospitalisation. Additionally, the adverse events reported and solved by Nutrihome© not only reduced the physicians' burden during those tough times and the patients´ stress of being hospitalised during a pandemic, but supported the entire healthcare system.
- Published
- 2023
- Full Text
- View/download PDF
13. [Comparison of differentiated thyroid carcinoma staging systems in a Spanish population].
- Author
-
Andía Melero VM, Martín de Santa-Olalla Llanes M, Sambo Salas M, Percovich Hualpa JC, Motilla de la Cámara M, and Collado Yurrita L
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cell Differentiation, Child, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Retrospective Studies, Spain, Young Adult, Adenocarcinoma, Follicular pathology, Carcinoma, Papillary pathology, Neoplasm Staging methods, Thyroid Neoplasms pathology
- Abstract
Background and Objective: Differentiated thyroid carcinoma staging is increasingly important due to the current trends to a less intensive therapy in low-risk patients. The TNM system is most widely used, but other systems based on follow-up of several patient cohorts have been developed. When these systems have been applied to other populations, results have been discordant. Our study evaluates the suitability of several differentiated thyroid carcinoma staging systems in a Spanish population., Material and Method: 729 patients with differentiated thyroid carcinoma and staging data available were enrolled. Mean follow-up time was 10.8 years. The TNM, EORTC, AMES, Clinical class, MACIS, Ohio, NTCTCS, and Spanish systems were applied to all histological types. The Kaplan-Meier survival curves for each system were analyzed, and compared using the proportion of explained variation (PEV)., Results: The demographic and clinical characteristics of our population were similar to those of other Spanish and international cohorts reported. The best systems were NTCTCS, with 74.7% PEV, and TNM (68.3%), followed by the Ohio, MACIS, EORTC, and AMES systems with minimal differences between them, while the least adequate were the Spanish (55.2%) and Clinical class (47.1%) systems., Conclusion: The NTCTCS staging system was found to be better than TNM in our population but, because of its simplicity and greater dissemination, the TNM appears to be recommended for staging of patients with differentiated thyroid carcinoma., (Copyright © 2014 SEEN. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.